Abiopharma

CENTRAL SECURITIES CORP (CET)

Symbol	CET
Name	CENTRAL SECURITIES CORP
Sector	FINANCE
Region	UNDEFINED
Industry	Finance/Investors Services
Address	630 FIFTH AVENUE, NEW YORK, NY 10111
Telephone	212-698-2020
Fax	—
Email	—
Website	https://www.centralsecurities.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	—
Description	Primary investment objective is growth of capital. Income received from securities is a secondary consideration. Additional info from NASDAQ: Primary investment objective is growth of capital. Income received from securities is a secondary consideration.

2026-04-28 20:15

Central Securities Corporation Releases Report to Stockholders

2026-04-28 16:25

New Form N-30B-2 - CENTRAL SECURITIES CORP Filed: 2026-04-28 AccNo: 0001999371-26-009246 Size: 158 KB

2026-04-24 13:10

ENDEAVOR FOUNDATION, INC. 🔴 sold 18.8K shares of CENTRAL SECURITIES CORP (CET) Transaction Date: Apr 22, 2026 | Filing ID: 000033

2026-03-30 16:19

ENDEAVOR FOUNDATION, INC. 🔴 sold 20.2K shares of CENTRAL SECURITIES CORP (CET) Transaction Date: Mar 26, 2026 | Filing ID: 000031